Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-29

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the current study is to assess complete coronary physiology (FFR, RFR, CFR, IMR, and CT-FFR) in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI. This aims to determine how TAVI affects coronary blood flow and coronary microcirculatory function after longer-term follow-up, and how these effects influence FFR and RFR values. In addition, it is aimed to correlate invasive functional testing (FFR and RFR) with non-invasive CT-FFR before and 6 months after TAVI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities

NCT04663334

Severe Symptomatic Aortic Stenosis

COMPLETED

Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.

NCT04009434

Aortic Stenosis Mitral Regurgitation

UNKNOWN NA

Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions

NCT05374733

Aortic Valve Stenosis Mitral Regurgitation Coronary Artery Disease +1 more

UNKNOWN NA

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

NCT03863132

Aortic Valve Stenosis

ACTIVE_NOT_RECRUITING NA

Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation

NCT04503655

Aortic Valve Stenosis Cardiovascular Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective, single center, open-label study to

1. compare coronary flow reserve (CFR), index of microvascular resistance (IMR), fractional flow reserve (FFR) and resting full cycle ratio (RFR) values before TAVI and 6 months after TAVI
2. correlate testing of microcirculatory function (IMR) with measurements of functional testing (FFR and RFR) before and six months after TAVI
3. correlate functional testing (FFR and RFR) with computed tomography (CT) derived fractional flow reserve (CT-FFR) before and six months after TAVI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Stenosis Transcatheter Aortic Valve Implantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Prospective, single center, open-label

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coronary physiology

Assession of complete coronary physiology in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI.

Group Type OTHER

Assession of complete coronary physiology

Intervention Type PROCEDURE

Assession of complete coronary physiology in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assession of complete coronary physiology

Assession of complete coronary physiology in TAVI candidates with intermediate coronary artery stenosis before and 6 months after TAVI.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

FFR, RFR, CFR, IMR, and CT-FFR

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Willing to participate and able to understand, read and sign the informed consent document before the planned procedure
* Severe symptomatic aortic stenosis with indication for TAVI according to current guidelines deemed by the Heart Team
* Patients who have undergone coronary CT angiography before TAVI in which CAD could not be ruled out
* CAD in one or more native major epicardial vessels or their branches by coronary angiogram with visually assessed coronary stenosis, in which the physiological severity of the lesion is in question (typically 40-90% diameter stenosis).
* Eligible for invasive coronary angiography and functional assessment (FFR, RFR, CFR and IMR)
* Eligible for coronary CT-angiography and functional assessment (CT-FFR)

Exclusion Criteria

* Patients whose CT-angiography was determined to be non-diagnostic/unreadable during its evaluation
* Previous coronary artery bypass grafting with patent grafts to the interrogated vessel
* Patients with severe lesions with a diameter stenosis ≥ 90%, flow-limiting lesions, or a significant left main coronary artery stenosis
* Critical coronary artery disease deemed by the Heart Team to require immediate revascularization
* Contraindication to adenosine (e.g. bronchial asthma)
* Chronic renal impairment with severe reduction of glomerular filtration rate (eGFR \<30 ml/min)
* Presence of cardiogenic shock
* Participation in another interventional study involving the left heart or coronary arteries

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No